Targeting metabolism to regulate immune responses in autoimmunity and cancer
Year: 2019
Type: review
Source: Nature Reviews Drug Discovery
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Awards: A central role for mTOR in Determining T Cell Activation versus Tolerance, Cell-targeted glutamine antagonists as a novel therapy for lymphoma, Immunotherapy induced Trm arrest and reverse lung fibrosis, Targeting Tumor Metabolism as a Means of Enhancing Immunotherapy, Cellular and Molecular Mechanisms of Immune Inflammatory Reactions, Pathophysiology of Myocardial Disease
OpenAlex ID: W2965632634
